Skip to main content
Back
Activeted-487559-2026

Supply of Imlifidasa Immunosuppressants

Regular supply of medicinal products for parenteral administration containing the active substance Imlifidasa (ATC group L04AA41) for the treatment of hospitalized patients in approved indications according to SPC.

CZK 102,500,000
View original source

CONTRACTING AUTHORITY

Name

Institut klinické a experimentální medicíny

City

Praha

Country

CZ

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33652300, Immunosuppressive agents.

ADDITIONAL DETAILS

EU Funded

Yes

Electronic Submission

Required

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

28 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

28 days remaining

Similar Tenders

Explore CPV 33
CZK 23.8M

Albuminum humanum Infusion Solutions III. – joint procurement 2026

Supply of Albuminum humanum infusion solutions in various concentrations and package sizes for joint procurement 2026.

Institut klinické a experimentální medicíny

·Praha
Deadline:August 18, 2026
CZK 5.6M

X-ray system for biopsy room

Delivery of 1 X-ray system for a biopsy room: includes free warranty service and proper post-warranty service. Site visit: July 29, 2026, at 1:00 PM.

Institut klinické a experimentální medicíny

·Praha
Deadline:August 19, 2026
CZK 9.3M

Milled and Bakery Products for the Institute of Clinical and Experimental Medicine

Delivery of Milled and Bakery Products: recurring deliveries for the catering operations of the Institute of Clinical and Experimental Medicine; the product catalog is listed in NEN and will be updated in individual mini-tenders.

Institut klinické a experimentální medicíny

·Praha
Deadline:August 18, 2026
CZK 4.8M

Corticosteroids for systemic use

Supply of medicinal products containing the active substance Prednisone (ATC H02AB07) for oral administration for the treatment of patients in approved indications. Prednisone in 5 MG/tablet strength is mandatory. Additional strengths (2.5 MG/tablet, 10 MG/tablet, 20 MG/tablet) are optional; the breadth of the portfolio will be evaluated.

Institut klinické a experimentální medicíny

·Praha
Deadline:August 27, 2026

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now